Piramal Healthcare, an innovation led company, has completed the acquisition of a US based company in the healthcare information segment - ‘Decision Resources Group’ for a consideration of approximately $635 million (around Rs 3,400 crore). The company will now operate Decision Resources Group as a stand-alone business.
Decision Resources Group (DRG) is focused on three market segments - the Biopharma business unit; the Market Access business and the Medical Technology business. The successful acquisition of DRG reflects the company’s strategy to continue investing in strong intellectual property in the healthcare space.
DRG provides high quality, web-enabled research, predictive analytics via proprietary databases and consulting services to the global healthcare industry. With 20% CAGR for the last five years, it is one of the fastest growing companies in the $5.7 billion global healthcare information industry. DRG projects revenues of $160 million for 2012. 48 of the top 50 global pharmaceutical companies are its customers, with an overall customer retention rate of 95%.
Piramal Healthcare is an innovation led company with a growth track record of above 25% CAGR since 1988. Piramal, had consolidated revenues of $450 million in FY2012. With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 934.10 |
| Shriram Finance | 1036.45 |
| Aditya Birla Capital | 346.95 |
| Chola Invest & Fin. | 1579.90 |
| Tata Capital | 333.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: